These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19440739)

  • 1. Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.
    Zhang S; Shi Y; Jin H; Liu Z; Zhang L; Zhang L
    J Mol Model; 2009 Dec; 15(12):1481-90. PubMed ID: 19440739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR study of novel peptide aldehydes as inhibitors of 20S proteasome.
    Ma Y; Xu B; Fang Y; Yang Z; Cui J; Zhang L; Zhang L
    Molecules; 2011 Sep; 16(9):7551-64. PubMed ID: 21894088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.
    Li A; Sun H; Du L; Wu X; Cao J; You Q; Li Y
    J Mol Model; 2014 Nov; 20(11):2515. PubMed ID: 25394401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripeptide analogues of MG132 as protease inhibitors.
    Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD
    Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods.
    Zhu YQ; Pei JF; Liu ZM; Lai LH; Cui JR; Li RT
    Bioorg Med Chem; 2006 Mar; 14(5):1483-96. PubMed ID: 16256351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods.
    Culletta G; Zappalà M; Ettari R; Almerico AM; Tutone M
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.
    Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD
    ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic comparison of peptidic proteasome inhibitors highlights the α-ketoamide electrophile as an auspicious reversible lead motif.
    Stein ML; Cui H; Beck P; Dubiella C; Voss C; Krüger A; Schmidt B; Groll M
    Angew Chem Int Ed Engl; 2014 Feb; 53(6):1679-83. PubMed ID: 24403024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
    Guo N; Peng Z
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):6-11. PubMed ID: 22897979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics guided discovery of flavopeptins: anti-proliferative aldehydes synthesized by a reductase domain-containing non-ribosomal peptide synthetase.
    Chen Y; McClure RA; Zheng Y; Thomson RJ; Kelleher NL
    J Am Chem Soc; 2013 Jul; 135(28):10449-56. PubMed ID: 23763305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design, synthesis and biological assay of novel tripeptidic tetrazoles as inhibitors of 20S proteasome].
    Ma YH; Xu B; Cui JR; Yang ZJ; Zhang LR; Zhang LH
    Yao Xue Xue Bao; 2012 Apr; 47(4):472-8. PubMed ID: 22799029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome.
    Arba M; Nur-Hidayat A; Ruslin ; Yusuf M; Sumarlin ; Hertadi R; Wahyudi ST; Surantaadmaja SI; Tjahjono DH
    Comput Biol Chem; 2018 Jun; 74():230-238. PubMed ID: 29674291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.
    Vivier M; Jarrousse AS; Bouchon B; Galmier MJ; Auzeloux P; Sauzieres J; Madelmont JC
    J Med Chem; 2005 Oct; 48(21):6731-40. PubMed ID: 16220988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.
    Dong XW; Zhang JK; Xu L; Che JX; Cheng G; Hu XB; Sheng L; Gao AH; Li J; Liu T; Hu YZ; Zhou YB
    Eur J Med Chem; 2019 Feb; 164():602-614. PubMed ID: 30639896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.
    Lei B; Abdul Hameed MD; Hamza A; Wehenkel M; Muzyka JL; Yao XJ; Kim KB; Zhan CG
    J Phys Chem B; 2010 Sep; 114(38):12333-9. PubMed ID: 20812720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.
    Liu H; Wu J; Ge Y; Li A; Li J; Liu Z; Xu Y; Xu Q; Li Y
    Bioorg Med Chem; 2018 Mar; 26(5):1050-1061. PubMed ID: 29426629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome.
    Arba M; Nur-Hidayat A; Surantaadmaja SI; Tjahjono DH
    Comput Biol Chem; 2018 Dec; 77():64-71. PubMed ID: 30243108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the ubiquitin/proteasome pathway in pollen tube growth with emphasis on MG132-induced alterations in ultrastructure, cytoskeleton, and cell wall components.
    Sheng X; Hu Z; Lü H; Wang X; Baluska F; Samaj J; Lin J
    Plant Physiol; 2006 Aug; 141(4):1578-90. PubMed ID: 16778013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.